Revenue segments as reported by the company.

Net revenue, before excise taxes

Excise taxes

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Sales and marketing

Research and development

General and administrative

Restructuring costs

Share-based payments

Depreciation and amortization

Impairment loss on goodwill and indefinite-lived intangible assets

Impairment loss on long-lived assets

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Cronos Group

Cronos Group, Inc. engages in the production and distribution of cannabis. Its brands include PEACE NATURALS, COVE, Spinach, Lord Jones, and PEACE+. The company was founded by Lorne Michael Gertner and Paul Rosen on August 21, 2012 and is headquartered in Toronto, Canada.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Cronos Group, Inc. engages in the production and distribution of cannabis. I It operates through the Canada and Israel segments. The company was founded on August 21, 2012 and is headquartered in Toronto, Canada.

Aurora Cannabis

Aphria

Canopy Growth

Tilray Brands

An Australian JV set up by Cronos is launching an IPO, while Canopy Growth is shedding its stake in a company there.

Marijuana Stocks Make These Moves In A New Cannabis Market

Canadian cannabis company Cronos Group Inc. CRON, +5.79% said Wednesday its 50/50 joint venture with NewSouthern Capital Pty Ltd.

Canadian cannabis company Cronos says Australian joint venture is planning a November IPO

TORONTO, Oct.  16, 2019  (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”) today noted the separately announced AUD$20 million initial public offering of Cronos Australia Limited (“Cronos Australia”). Under the offering, Cronos Australia is expected to issue 40 million new shares at an offering price of AUD$0.50 per share (the “Cronos Australia IPO”) ahead of its planned listing on the Australian Securities Exchange in November 2019.

Cronos Group Issues Statement on Separately Announced IPO of Cronos Australia

HEXO Corp

Altria

A terrible year for pot stocks may get even worse.

Marijuana Stocks Could Have 30% Downside, According to 1 Wall Street Firm

CRON stock is down more than 50% on concerns about slowing cannabis growth in Canada and vaping-related health concerns. However, there are plenty of reasons for long-term investors to buy the dip.

4 Reasons to Buy Cronos Stock On the Vaping Dip

Cronos stock has held up better than many of the other cannabis stocks but there is a chance that may soon be changing
The post There Probably Is a Lot More Bad News Ahead for Cronos Stock appeared first on InvestorPlace.
More From InvestorPlace
		
					
				
					2 Toxic Pot Stocks You Should Avoid				
			
					
				
					7 Beverage Stocks to Buy Now				
			
					
				
					10 Groundbreaking Technologies Created by Universities				
			
					
				
					5 Semiconductor Stocks Worth Your Time

There Probably Is a Lot More Bad News Ahead for Cronos Stock

The Marijuana Massacre

In about a month, we'll have the latest figures from the Canadian cannabis company.

Cronos Group Sets Q3 Results Release Date

Imperial Brands PLC

With mysterious vape-related lung illnesses on the rise in the U.S., this study's findings are unwelcome news.

Uh-Oh! A New Study Links Vaping to Cancer in Mice

Marijuana stocks were mixed Friday, even as a Jefferies analyst made deep cuts to price targets on Aurora Cannabis and Canopy Growth.

Marijuana Stocks: Pot Producers' Price Targets Slashed After Six Months Of Bad News

Health impact of vaping makes CRON stock a concern from a regulatory and growth perspective. Keep it on the investment radar, but shares aren't likely to trend higher anytime soon.

Avoid Cronos Group Stock Even After Yesterday’s Cannabis Carnage

Coupa Software

Freeport-McMoRan

Here are the top stock trades we’re watching for Friday morning

5 Top Stock Trades for Friday: FCX, COUP, APHA, CRON & HEXO

CRON stock continues to plunge, and with near-term profits unlikely and valuation still high, the declines may well continue.
The post CRON Stock Still a Falling Knife Without a Catalyst appeared first on InvestorPlace.

CRON Stock Still a Falling Knife Without a Catalyst

Hysteria over the vaping crisis has hurt CRON stock. But investors should have patience until all the facts are straightened out.

Here’s How the Mandela Effect Has Hurt Cronos Group Stock

Cannabis stocks had a huge showing on Wall Street last year. In fact, most of the news flow surrounding these stocks had investors pouring money into them.

Cannabis Stocks Spark Short Interest Growth

In just six months, Wall Street's outlook for Canada's biggest cannabis players has deteriorated in a big way.

Sales Estimates for Aurora, Canopy, and Cronos Are Plunging

HubSpot

Snap

Atlassian

Workday

These companies dole out a ton of stock as employee compensation, and that may be contributing to overvalued stocks.

5 Overvalued Stocks With Too Much Stock-Based Compensation

Cannabis stocks are down, but they aren't out just yet. Instead, the growth fundamentals imply tremendous long-term upside for a few names.

Don’t Give Up on These 4 Cannabis Stocks

Brand-name cannabis stocks have officially lost their luster.

Marijuana's "Big Four" Lost Nearly $14 Billion in Value During the Third Quarter

Recent vaping incidents have vexed cannabis investors.

Why Marijuana Stock Cronos Group Plunged 18% in September

CRON stock has dropped dramatically. This could potentiall lead to a shakeup in the senior management of the company
The post Nothing About a Management Shakeup Improves Cronos Stock appeared first on InvestorPlace.

Nothing About a Management Shakeup Improves Cronos Stock

Long-term upside in CRON stock is compelling, but the bull thesis lacks conviction and clarity at the current moment.
The post Why Investors Should Continue to Avoid Cronos Stock appeared first on InvestorPlace.

Why Investors Should Continue to Avoid Cronos Stock

With vaping-related illnesses on the rise, health concerns could impact the success of a new wave of cannabis products set to launch in Canada later this year.

Vape Sales are Falling: Why this Could Be Bad News for Canadian Cannabis Companies

An announcement could come as early as next week, sources say.

Report: Ontario Might Abandon Wholesale Cannabis Sales

Cronos Group (CRON) closed the most recent trading day at $8.96, moving -0.99% from the previous trading session.

News for Cronos Group Stock (CRON)